The U.S. Food and Drug Administration has approved a brainwave-measuring device to help diagnose kids with ADHD, a first for the disorder.
The device detects two different types of brainwaves, theta and beta, and how frequently they occur. Kids with attention-deficit/hyperactivity disorder have more theta than beta brainwaves, compared to kids without ADHD.
The FDA approved the device, called the Neuropsychiatric Electroencephalogram-Based Assessment Aid or NEBA, for use with a full medical exam. In a statement, the director of the agency's Office of Device Evaluation, Christy Foreman, emphasized that the device has to work with other clinical measures.
Click on the link below to read the full article
Category(s):Attention Deficit Hyperactivity Disorder (ADHD)
Source material from Pop Science
